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As a result of thermolysin hydrolysis of a coat protein (CP) of Potato Virus M Ukrainian Strain UJ 
(PVM)i the heptapeptide 29AADFEGJCS was found to be recognised by two PVM specific monoclonal 
antibodies (MAbs) M6D5 and M9GJ. This heptapeptide represents the C-terminal part of tryptic 
tetradecapeptide 2iEARPLPTAADFEGKis (P14) which was also recognised by the same MAbs. The 
peptides represented sequences of tryptic (P14)t thermolysinic (P7) fragments and three heptapeptides 
containing alanine substitutions for Asp31 and Glu33f were synthesised to determine the contribution of 
dicarbonic amino acids in the antigen-antibody interaction. All synthetic heptapeptides were recognised by 
both MAbs weakly in indirect ELISA. These peptides were also used as inhibitors of MAb-CP and 
MAb-P 14 reactions in inhibition ELISA. The results of inhibition ELISA have shown the following: 1) the 
same concentrations of peptides were more effective to inhibit the interaction of MAbs with P14 than with 
CP; 2) substitutions of charged amino acids decreased noticeably the ability of peptides to inhibit the 
antigen-antibody interaction, especially the substitution of Asp31; 3) heptapeptides containing alanine 
substitutions suppressed more effectively the interaction of MAb M6D5 with antigens and were less effective 
to inhibit the reaction of MAb M9G1 with the same antigens. Thust the difference in Asp31 and Glu33 
contributions to the antigen-antibody complex formation has been found. 
Introduction. Previously the antigenic analysis of two 
Potato Virus M Ukrainian strains (PVM Ul and U7) 
was carried out with the use of three monoclonal 
antibodies (MAbs M6D5, M9G1 and M4C1) [1]. The 
PVM-specific epitopes were established to be located 
in the N-terminal region of the coat protein (CP) and 
sequentially overlapped each other [1 ]. In that study 
the tryptic fragments 22Glu-Lys35 (PVM Ul) and 
22Gly-Lys35 (PVM U7) were recognised by two MAbs 
M6D5 and M9G1. The amino acid substitution Glu-» 
-*Gly at the position 22 of PVM U7 CP did not affect 
the antibody binding of the tryptic peptide and PVM 
U7 CP. It was shown that MAb M9G1 interfered with 
MAb M4C1 for binding PVM CP sites in the dot 
immunobinding assay. The synthetic peptide P14, 
corresponding to the tryptic fragment 2 Glu-Lys35, 
inhibited the MAbs M6D5 and M9G1 interaction with 
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CP and peptide P14 with different level of ELISA 
inhibition. The modification of the side chain positive 
charge of Lys35 to negative one in tryptic peptides 
22Glu-Lys35 and 22Gly-Lys35 using citraconic anhyd-
ride, resulted in two-fold increase of the MAb M9G1 
reaction and slightly reduced the MAb M6D5 inter-
action with both fragments. On the basis of these 
results, it was concluded that: 1) PVM-specific epi-
topes are located at the N-terminal region of PVM 
coat protein; 2) MAbs M6D5 and M9G1 recognise 
sequentially overlapping epitopes and the common 
part of both epitopes is presented in the 2 2GWGly-
Lys35 fragment; 3) MAbs M4C1 and M9G1 recognise 
either overlapping or conformational approximated 
epitopes. Also it was suggested that the region at 
position 34—49 of PVM CP is disposed to form the 
loop with я-turn [1 ]. 
In the present study the synthetic heptapeptides 
containing alanine substitutions of dicarbonic amino 
acids were used for more detailed analysis of PVM 
epitopes. 
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Materials and Methods. Virus purification. PVM 
Ul strain was purified as described in [2], using 
50 mM K H 2 P O 4 - K O H buffer with 5 mM EDTA and 
0.2 % 2-mercaptoethanol, pH 7.5, and 0.3 M glycine-
KOH buffer, pH 8.5. All purification procedures were 
performed at 4 °С. The virus concentration was 
estimated assuming the extinction coefficient at 
260 nm of 2.88 cm^mg 1 . T h e A2607280 = 1.21, 
Amax7min =1.12 ratios [3] and SDS-electrophoresis [4] 
were used to analyse purity and quality of virus 
preparations. The purified virus were stored at -20 0C 
in 0.3 M glycine-KOH buffer, pH 8.5, containing 
С Л о/ 
/О feA^^^i^A. 
Coat protein preparation. PVM Ul coat protein 
(CP Ul) was prepared according to [5]. The purified 
virus at the concentration of 3—5 mg/ml in the 0.3 M 
glycine-KOH buffer, pH 8.5, was treated with the 
mixture of guanidine-HCl and LiCl at the final 
concentration of 4 M and 2 M, respectively, and 
followed by freezing at -70 °С for 3 h and thawing at 
room temperature. The precipitated virus RNA was 
collected by centrifugation at 5000 g for 30 min. The 
supernatant containing coat protein was dialysed 
against ammoniac water, pH 8.0, and lyophilised. The 
protein concentration was estimated according to 
Lowry et al. [6 ]. 
Proteolytic cleavage of PVM coat protein. CP Ul 
was digested with thermolysin («Sigma», USA) in 
0.1 M ammonium bicarbonate, pH 8.0, at 37 °С for 
4 h at the enzyme-substrate ratio 1:100 (w/w). The 
reaction was stopped by adding 0.1 % acetic acid to 
pH 2.5. The thermolysin-treated proteins were stored 
at -20 °С. 
Fractionation of thermolysinic peptides and se-
quencing. CP Ul thermolysinic mixture was fra-
ctionated by High Performance Liquid Chromato-
graphy (HPLC) on a C18 LiChrosorb RP-18 column 
(5 μτη, 4.6 mm χ 250 mm, «LKB», Sweden) using the 
2—60 % linear gradient of acetonitrile («Fluka», 
Switzerland) in 0.1 % trifluoroacetic acid (TFA) at 
the flow rate of 1.0 ml/min. Optical density was 
monitored at 206 nm and 280 nm. The collected 
fractions were dried and peptide material of each 
fraction was dissolved in an appropriate buffer before 
using in further experiments. 
The thermolysinic fractions found to be recog-
nised by MAbs were repeatedly fractionated using the 
same column and combination of linear gradient 
(2—40 %) and isocratic acetonirtile elution in 0.1 % 
TFA. The amino acid sequence analysis was per-
formed in a gas sequenator, model 816 («Knauer», 
Germany), according to the manufacturer protocol. 
Peptide synthesis. Synthetic peptides P14 (H2N-
22EARPLPTAADFEGK35-COOH), P7 <H2N-29AADF-
EGK35-COOH), P l (H2N-29AAAFEGK35-COOH), P2 
( H 2 N - 2 9 A A D F A G K 3 5 - C O O H ) , Р З ( H 2 N - 2 9 A A A F A G -
K3^-COOH) and peptide H2N-154KDASSSVF,61-CO-
OH as a negative control were synthesised (NPO 
Verta, St.-Petersburg, Russia) by the solid phase 
method using Boc-protected amino acids, according to 
[7 ] . 
ELISAs. Lyophilised protein and vacuum dried 
peptide samples were dissolved in phosphate buffered 
saline: 10 mM Na2HPO4-NaH2PO4, pH 7.3, con-
taining 0.14 M NaCl (PBS). Microtiter plates 
(«Nunk», Denmark) were costed with antigens bv 
evaporating PBS at 37 0C overnight. Antigen-coated 
wells were rinsed with PBS and blocked with 1 % 
BSA in PBS for 4 h at 37 °С. MAbs were diluted in 
PBS containing 0.05 % Tween-20 (PBST) and 0.3 % 
BSA and incubated with antigens for 2 h at 37 °С. 
After this the plates were washed five times with 
PBST, and the rabbit anti-mouse IgG-horse radish 
peroxidase conjugate (1:2000) in PBST with 0.3 % 
BSA was added. The plates were incubated at 37 °С 
for 1.5 h and washed five times with PBST. A colour 
reaction was developed by adding substrate buffer 
(0.1 M citrate-0.15 M Na2HPO4, pH 4.5), containing 
0.6 mg/ml o-phenylenediamine («Fluka», Switzer-
land) and 0.01 % H2O2. ELISA optical density was 
measured at 450 nm using Kinetic Microplate Reader 
(Molecular Devices, «Fisher», USA). 
In the inhibition ELISA experiments, MAbs were 
incubated with two-fold decreasing concentrations of 
synthetic peptides P14, P7, PI , P2 and P3 for 1 h at 
room temperature. Then these mixtures were added 
to the precoated antigens CP Ul — 500 ng (14 pM) 
per well or peptide P l4 — 50 ng (33 pM) per well 
with following incubation for 1 h at 37 °С. The other 
steps of inhibition ELISA were performed as des-
cribed above in ELISA procedure. 
Further in the text all concentrations of antigens 
and inhibitors mean the amount of the material per 
well. 
Monoclonal antibodies. MAbs M6D5, M4C1 and 
M9G1 were raised against native virus particles of 
PVM-Russian strain and were characterised earlier 
[8 ]. Professor M. Saarma, Institute of Chemical 
Physics and Biophysics (Estonia) has kindly provided 
the antibodies for this study. 
Results and Discussion. For the further study of 
PVM antigenic structure the thermolysin hydrolysis 
of PVM CP was carried out. The products of pro-
teolytic cleavage were fractionated by HPLC using 
linear acetonitrile gradient. The fractions collected 
were tested by indirect ELISA using three MAbs, 
M6D5, M4C1 and M9G1. MAb M4C1 did not re-
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cognise any thermolysinic fraction while MAbs M6D5 
and M9G1 reacted with fraction 17. After additional 
HPLC purification using a combination of linear 
gradient and isocratic acetonitrile elution it has been 
shown, that fraction 17 consists of three subfractions: 
17,, 172 and 173. Only subtraction 173 was recognised 
by MAbs M6D5 and M9G1 in ELISA. The primary 
structure of 173 subfraction peptide AADFEGK was 
established on a gas sequenator. The sequence of this 
heptapeptide corresponds to the fragment of PVM 
Russian strain CP [9] at the positions 29—35 and 
represents the C-terminal part of tryptic tetrade-
capeptide 22EARPLPTAADFEGK35 that was also reco-
gnised by MAbs M6D5 and M9G1 [1]. 
In previous work [1 ] we pointed out that lack of 
reaction between MAb M9G1 and lengthened peptides 
22Glu/Gly-Arg44 may be caused by structural changes 
in the C-terminal region of this fragment after protein 
cleavage by trypsin. These structural changes did not 
affect the recognition of 22GWGly-Arg44 peptides by 
MAb M6D5. The similar phenomenon, when the 
antibody recognised the short peptide and did not 
recognise the lengthened peptide, have been observed 
by other investigators [10, 11] and had no exp-
lanation until present. In our case we suggested that 
region 34Gly-Asp49 formed the loop with л:-turn [12] 
and some of M9G1 epitope's amino acids were 
involved in the formation of this structure. The 
enzymatic destruction of PVM CP resulted in drastic 
distortions of the я-turn structure and abolished the 
recognition of M9G1 epitope in peptides 2 2GWGly-
Arg44 by corresponding MAb, whereas the main 
portion of M6D5 epitope located out of the лг-turn 
structure and both peptides 22Glu/Gly-Lys35 and 
22Glu/Gly-Arg44 were recognised by MAb M6D5. 
Thus, most likely, the M6D5 epitope is located at the 
N-terminal part while M9G1 epitope is shifted to the 
C-terminal part of 22GWGly-Arg44 fragment [1 ]. 
On the basis of ELISA of thermolysinic frag-
ments, the linear heptapeptide AADFEGK (P7) was 
synthesised. Additionally, the following peptides, con-
taining alanine substitutions of charged amino acid 
were synthesised: 1) peptide AAAFEGK (Pl) with 
Asp31 Ala substitution; 2) peptide AADFAGK (P2) 
with Glu33 Ala substitution; 3) peptide AAAFAGK 
(P3) with Asp31 Ala and Glu33 Ala simultaneous 
substitutions. The alanine substitutions can help to 
find out the contribution of negatively charged amino 
acids in the MAb-antigen interaction. Generally ac-
cepted, that in most cases one amino acid substitution 
on the protein molecule surface resulted only in local 
changes, although the mutations are known that alter 
the distant regions conformation and thus have an 
indirect effect on antigenicity [13—16]. 
In indirect ELISA MAbs M6D5 and M9G1 reac-
ted with 500 ng (14 pM) of CP equally (E450 = 2.5), 
while the reaction of MAb M6D5 with synthetic 
peptide P14 (50 ng or 33 pM) E450 = 2.6 was sig-
nificantly higher then of MAb M9G1 (E450 = 1.4). The 
difference in reactions between MAbs and peptide 
P14 shows that only the part of M9G1 epitope is 
presented in peptide P14, whereas this peptide con-
tains the most part of M6D5 epitope. Above men-
tioned concentrations of CP and peptide P14 were 
used as coating concentrations in inhibition ELISA. 
Synthetic peptides (P7, PI , P2 and P3) were 
analysed in indirect and inhibition ELISA formats. In 
indirect ELISA MAbs M6D5 and M9G1 detected the 
peptide P7 at the minimal concentrations of 10 pM 
(7 ng) and 1 nM (700 ng), respectively, while pep-
tides PI, P2 and P3 were not recognised by the 
antibodies at the concentration of 100 nM. The results 
of analysis of synthetic peptides P7, PI , P2 and P3 
as coating antigens were highly contradictory and the 
level of MAbs reaction did not correlate with peptide 
concentrations. 
This effect can be referred to very poor ad-
sorption of short peptides to the plate material that 
leads to decrease or lack of ELISA reaction. Usually, 
to avoid such problem, the short peptides are used as 
inhibitors of the interaction between antibodies and 
antigens. In our study we used this approach to 
analyse the abilities of synthetic peptides P7, PI, P2 
and P3 to inhibit the reaction of MAbs M6D5 and 
M9G1 with PVM CP and synthetic peptide P14. 
Synthetic peptide i55DASSSVF1 61 was used as a nega-
tive control and displayed any inhibition capability in 
MAb-CP and MAb-Pl4 reactions. 
The inhibition ELISA results showed that pep-
tides P7, PI , P2 and P3 inhibited the interaction 
between MAbs and CP or P14 with various effec-
tiveness. 50 % inhibition of the M6D5-P14 and 
M9G1-P14 interactions was achieved using following 
concentrations of inhibitors (C50): 17 and 22 pM of P7 
and 24 pM and 12 nM of P14, respectively (Fig. 1, 
2). Maximum 95—96 % inhibition activity of peptide 
P7 was observed at concentration 390 pM (Cmax). In 
the range of 1.5—100 pM concentrations of peptide 
P7 inhibited the reaction M9G1-P14 weaker, than the 
reaction M6D5-P14 (Fig. 1, lines 2 and 7, res-
pectively). The reaction M9G1-P14 was more ef-
fectively inhibited with peptide P7 (Fig. 1, line 2) 
than with peptide P14 (Fig. 2, line 3): C50 = 22 pM 
and 12 nM, respectively. Peptide P7 at the con-
centration of 390 pM caused the 96 % suppression of 
M9G1-P14 interaction (Fig. 1, line 2), while the same 
molar concentration of peptide P l4 suppressed only 
8 % of this reaction (Fig. 2, line J). 95 % of Pl4 
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Fig. 1. Inhibition of M6D5-P14 and M9G1-P14 interactions with the 
use of synthetic peptides P7 and Pl4 as inhibitors. Lines: 1 — 
inhibition of M6D5-P14 interaction by peptide P7; 2 — inhibition of 
M9G1-P14 interaction by peptide P7; 3 — inhibition of M6D5-P14 
interaction by peptide P14. Coating concentration of peptide Pl4 
was 50 ng (33 pM). MAbs were used at the next dilutions: M6D5 — 
1:1000, M9G1 — 1:500. The vertical dotted lines ( ) mark the 
inhibitor concentrations required for 50 % inhibition of antibody-
antigen interaction. Negative control data are not shown 
Fig. 2. Inhibition of MAbs-CP and MAbs-P 14 interactions with the 
use of peptides P7 and Pl4 as inhibitors. Lines: 1 inhibitor P14, 
interaction M6D5-CP; 2 — inhibitor P7, interaction M6D5-CP; 3 — 
inhibitor P14, interaction M9G1-P14; 4 — inhibitor P14, interaction 
M9G1-CP. Coating concentration of CP was 500 ng (13 pM), of 
peptide Pl4 — 50 ng (33 pM). MAbs were used at the next 
dilutions: M6D5— 1:1000, M9G1 — 1:500. Vertical dotted lines 
(- - -) mark the inhibitor concentrations required for 50 % in-
hibition of the antibody-antigen interaction 
inhibition effect was achieved at the concentration of 
200 nM (Fig. 2). 
The higher concentrations of peptide P7 were 
required to inhibit the MAbs-CP interaction in com-
parison with MAbs-P 14. 50 % inhibition of M6D5-CP 
reaction was achieved in the presence of 2.5 and 2.2 
nM of peptides P7 and P14, respectively, and Craax of 
both peptides were 200 nM (Fig. 2, lines 7, 2). The 
interaction M9G1-CP was suppressed by 50 % with 
136 nM of peptide P14 (Fig. 2, line 4). These results 
showed that conformation of peptide P7 was more 
appropriate for MAb M9G1 paratope while the peptide 
P14 was stronger inhibitor of reactions M6D5-
CP/P14. 
The results of inhibition ELISA of MAbs-CP and 
MAbs-PH interactions using peptides PI, P2 and P3 
as inhibitors are presented in Fig. 3 and 4. 50 % 
inhibition of M6D5-P14 reaction (Fig. 3) was achi-
eved at the concentrations of peptide Pl 10.5 nM (line 
2), P2 — 5 nM (line 7), P3 — 100 nM (line 5). The 
same inhibition effect of M6D5-CP reaction was 
observed at the following peptide concentrations: 
Pl — 36 nM (line 4)y P2 — 17.5 nM (line 3); peptide 
P3 (line 6) did not show 50 % inhibition at the used 
concentration range. 
Peptides PI, P2 and P3 revealed poor inhibition 
abilities in M9G1-CP and M9G1-P14 reactions (Fig. 
4), and only peptide P2 suppressed reaction M9G1-
P14 at C50 = 38 nM (Fig. 4, line 7). Peptide P7 with 
an original sequence almost completely suppressed the 
interaction MAbs-P 14 at Cmax = 390 pM (Fig. 1, lines 
7, 2), while peptide P2 at the concentration of 200 nM 
showed 90 % and 97 % inhibition of M9G1-P14 (Fig. 
4, line 7) and M6D5-P14 (Fig. 3, line 7) reactions, 
respectively. 200 nM of peptide P2 suppressed by 
92 % and 35 % reactions M6D5-CP (Fig. 3, line 3) 
and M9G1-CP (Fig. 4, line 2), respectively. Peptide 
P7 inhibited by 97 % the M6D5-CP reaction (Fig. 2, 
line 2). 
200 nM of peptide Pl containing the alanine 
substitution of aspartic acid inhibited by 94 % and 
10 % the interactions M6D5-P14 (Fig. 3, line 2) and 
M9G1-P14 (Fig. 4, line 4), respectively. The same 
peptide inhibited by 83 % and 2 % the interaction 
M6D5-CP (Fig. 3, line 4) and M9G1-CP (Fig. 4, line 
5), respectively. 
Simultaneous substitution of Asp31 and Glu33 in 
peptide P3 decreased drastically the ability of this 
peptide to inhibit the reaction of MAbs with both 
antigens. At the concentration 200 nM peptide P3 did 
not suppress completely any reaction, displaying 
72 % and 33 % of inhibition in M6D5-P14 (Fig. 3, 
line 5) and M6D5-CP (Fig. 3, line 6) interactions, 
respectively. The reactions of MAb M9G1 with CP 
and P14 were inhibited with 200 nM of peptide P3 by 
1 % (Fig. 4, line 6) and 18 % (Fig. 4, line 3), 
respectively. 
Thus, the comparison of inhibition abilities of 
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Fig. 3. Results of inhibition of interactions of MAb M6D5 with CP 
and Pl4 with the use of synthetic peptides with alanine substitutions 
as inhibitors. Lines: 1 — inhibition of M6D5-P14 interaction by 
peptide P2; 2 — inhibition of M6D5-P14 interaction by peptide PI; 
3 — inhibition of M6D5-CP interaction by peptide P2; 4 — in-
hibition of M6D5-CP interaction by peptide PI; 5 — inhibition of 
M6D5-P14 interaction by peptide P3; 6 — inhibition of M6D5-CP 
interaction by peptide P3. Coating concentration of CP was 500 ng 
(13 pM), of peptide Pl4 — 50 ng (33 pM). MAb was used at the 
dilution 1:1000. Vertical dotted lines (- - -) mark the inhibitor 
concentrations required for 50 % inhibition of the antibody-antigen 
interaction 
Fig. 4. Results of inhibition of the MAb M9G1 interactions with CP 
and Pl4 with the use of synthetic peptides with alanine substitutions 
as inhibitors. Lines: 1 — inhibitor P2, antigen P14; 2 — inhibitor 
P2, antigen CP; 3 — inhibitor P3, antigen Pl4; 4 — inhibitor PI, 
antigen Pl4; 5 — inhibitor PI, antigen CP; 6 — inhibitor P3, 
antigen CP. Coating concentration of CP was 500 ng (13 pM), of 
peptide P l4 — 50 ng (33 pM). MAb was used at the dilution 1:500. 
Vertical dotted lines (- - -) mark the inhibitor concentrations 
required for 50 % inhibition of the antibody-antigen interaction 
peptides P7, PI, P2 and P3 showed that peptide P3 
(Asp31 Ala and Glu33 Ala) was the weakest. Pep-
tide P2 (Glu33 Ala) maintained the highest residual 
inhibition activity in comparison with peptides Pl and 
P3. Peptide Pl (Asp31 Ala) also significantly affec-
ted the reactions of MAbs with both antigens. Pep-
tides PI, P2 and P3 were more effective inhibitors of 
MAb M6D5-antigen reactions (Fig. 3) than MAb 
M9G1-antigen reactions (Fig. 4). The same inhibitor 
(peptides P14, P7, PI, P2, P3) concentrations more 
effectively suppressed the interactions MAbs-P 14, 
than MAbs-CP. These data indicate that the native 
conformation and environment of this region in the 
protein molecule are very important for the interaction 
between MAbs and PVM epitopes, even if all critical 
residues of the epitopes are assumed to be located in 
the 22Glu-Lys35 region (peptide P14). 
In present study the contribution of individual 
residues (Asp31 and Glu33) in the MAb-antigen com-
plex formation has been evaluated using the alanine 
substitutions. It has been established that both resi-
dues Asp31 and Glu33 are involved in the M6D5 and 
M9G1 epitopes and contribute differently to the 
formation of the antigen-antibody complexes. Asp31 is 
more crucial residue of both epitopes than Glu33. Both 
amino acids Asp31 and Glu3 in M9G1 epitope are 
more important for recognition by corresponding MAb 
than the same residues in the structure of M6D5 
epitope. The simultaneous substitution of Asp31 and 
Glu33 in the M9G1 epitope drastically decreases the 
recognition of this epitope by the antibody that shows 
the key role of these residues in the epitope, while 
M6D5 epitope in the absence of Asp 1 and Glu33 
residues partially reserves the ability to be recognised 
by the corresponding antibody. It is obvious that 
neighbour amino acids in the M6D5 epitope consider-
ably contribute to the antigen-antibody complex for-
mation. 
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C, C. Вітер, T. Ю. Ткаченко, JJ. /7. Коломієць, 
Ю. JI. Радавський 
Характеристика епітопів М-вірусу картоплі з використанням 
синтетичних пептидів 
Резюме 
Після гідролізу білка оболонки (БО) українського штаму Vl 
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M-вірусу картоплі (PVM) термолізином виділено фрагмент 
29AADFEGK35 , який розпізнавався двома моноклональними 
антитілами (MKA) M6D5 та M9G1, специфічними до PVM. 
Цей гептапептцд є С-кіщевою частиною триптичного тет-
радекапептиду EARPLPTAADFEGK (П14), який розпіз-
навався тими самими MKA. Для визначення внеску негативно 
заряджених дикарбонових амінокислот у формування комплек-
су антиген—антитіло синтезовано синтетичні пептиди, що 
повторюють послідовності триптичного (П14) та термолі-
зинового (П7) фрагментів, а дгакож гептапептиди, які міс-
тили заміни Asp31 та Glu33 на аланін. Усі синтетичні 
гептапептиди слабко взаємодіяли з обома MKA в непрямому 
ІФА. Ці пептиди використовували як інгібітори взаємодії 
MKA-БО і МКА-П14. Результати інгібування ІФА показали, 
що: 1) однакові концентрації пептидів ефективніше інгибують 
взаємодію MKA з Π14, ніж із БО; 2) заміна заряджених 
амінокислот, особливо заміна Asp31 , значно зменшує здат-
ність пептидів пригнічувати взаємодію антиген—антитіло; 
3) гептапептиди, що містять заміни амінокислот на аланін, 
ефективніше пригнічують взаємодію MKA M6D5 з антигена-
ми та набагато слабше інгібують реакщір MKA ^Ol з тими 
самими антигенами. Таким чином, Asp та Glu по-різному 
впливають на формування комплексу антиген—антитіло. 
С. С. Витер, Т. Ю. Ткаченко, JI. П. Коломиец, Ю. JI. Радавский 
Характеристика эпитопов М-вируса картофеля с 
использованием синтетических пептидов 
Резюме 
После гидролиза белка оболочки (БО) украинского штамма Ul 
М-вируса картофеля (PVM) термолизином выделен фрагмент 
29AADFEGK35 , распознаваемый двумя моноклональными ан-
тителами (MKA) M6D5 и M9G1, специфичными к PVM. 
Этот гептапептид представляет собой С-концевой участок 
триптического тетрадекапептида 22EARPLPTAADFEG35 
(П 14), распознаваемый этими же MKA. Для определения 
вклада отрицательно заряженных дикарбоновых аминокислот 
в формирование комплекса антиген—антитело синтезирова-
ны синтетические пептиды, повторяющие последовательно-
сти триптического (П14) и термолизинового (П7) фрагмен-
тов, а также гептапептиды, содержащие замены Asp и Glu 
на аланин. Все синтетические гептапептиды слабо взаимодей-
ствовали с обоими MKA в непрямом И Φ А. Эти пептиды были 
использованы в качестве ингибиторов реакций МКА-БО и 
МКА-П 14. Результаты ингибирования ИФА показали, что: 1) 
одинаковые концентрации пептидов эффективнее ингибирова-
ли взаимодействие MKA с Π14, чем с Бр; 2) замена заряжен-
ных аминокислот, особенно замена Asp , значительно снижа-
ла способность пептидов ингибировать взаимодействие анти-
ген—антитело; 3) гептапептиды, содержащие замены амино-
кислот на аланин, эффективнее подавляли взаимодействие 
MKA M6D5 с антигенами и намного слабее ингибировали 
реалию MJ^ M9G1 с теми же антигенами. Таким образом, 
Asp и Glu вносят различный вклад в формирование комп-
лекса антиген—антитело. 
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